Actively Recruiting
PsyMINT Mobile Health Intervention to Support Pain and Symptom Self-Management for Cancer Survivors
Led by Virginia Commonwealth University · Updated on 2026-03-18
25
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
V
Virginia Commonwealth University
Lead Sponsor
N
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating a mobile health (mHealth) app-based behavioral intervention designed to help cancer survivors manage pain and symptoms after treatment. This pilot test aims to check the feasibility of using the PsyMINT app to deliver messages that support self-efficacy and pain self-management before expanding to a larger randomized controlled trial. The study focuses on survivors who have completed treatment and experience related pain. Participants will use the PsyMINT app for one week, receiving a series of 60 evidence-based intervention messages. The app will also prompt users to complete ecological momentary assessments twice daily and electronic diaries once daily. Message topics include pain management education, positive psychology, opioid literacy, skills for patient-provider communication and trust, and quality of life improvements. During the study, participants will be assessed at the start and end of the one-week intervention for feasibility and acceptability of the app. Researchers will also measure changes in pain management self-efficacy and quality of life using two standardized questionnaires. The study involves active user engagement and monitoring over one week to evaluate the app’s potential for broader use.
CONDITIONS
Brief Title
mHealth Intervention for Pain Self Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- In a post-treatment stage with no evidence of disease (complete remission)
- Diagnosed with cancer in the past three years
- Experiencing cancer/treatment-related pain
- 18 years of age or older at the time of first diagnosis
- Cognitively able to actively participate in an online-based study
- Able to read, write, and understand English
You will not qualify if you...
- Currently using medication for psychiatric reasons, including stimulants and mood stabilizers
- Diagnosed with major psychotic disorders such as bipolar disorder or schizophrenia, or substance use disorders
- Currently pregnant or planning to become pregnant in the next three months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 1 week
Participants use the PsyMINT mobile health app for 1 week, interacting with intervention messages, completing ecological momentary assessments twice daily, and filling out daily electronic diaries.
Daily app interactions and assessments
Trial Site Locations
Total: 1 location
1
Virginia Commonwealth University
Richmond, Virginia, United States, 23298
Actively Recruiting
Research Team
S
Sun Jung Kim, Ph.D
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here